PMHNP Scope of Practice for ADHD in Pennsylvania

If you’re a psychiatrist or PMHNP considering telehealth for ADHD care, you’ve probably wondered: Can I legally prescribe Adderall or other stimulants to patients I’ve never met in person? The short answer in 2026 is yes — but it’s complicated, temporary, and varies by state.

Let me walk you through what you actually need to know to practice legally, the state-by-state rules that matter most, and what’s coming down the pike that could change everything by 2027.

The Federal Picture: You’re Good Through 2026, But Changes Are Coming

Right now, federal law allows you to prescribe Schedule II stimulants (Adderall, Ritalin, Vyvanse) via telehealth without any in-person exam. This flexibility was extended for the fourth time in January 2026 and runs through December 31, 2026.

Here’s the background: The Ryan Haight Act normally requires an in-person medical evaluation before prescribing any controlled substance. During COVID, the DEA waived this requirement for telehealth appointments conducted via live audio-video. That waiver has been extended repeatedly while the DEA works on permanent rules — most recently through the end of 2026.

What this means for your practice today:

• You can evaluate a new ADHD patient via video consult
• You can prescribe stimulants after that initial telehealth visit
• You don’t need to see them in person first
• The prescription must be for a legitimate medical purpose and meet the standard of care
• You must use a real-time, two-way audio-visual connection (not phone-only, not just forms)

The catch? This extension is temporary. The DEA has announced three new permanent rules coming in 2027 that will likely require:

1. A special DEA Telemedicine Registration to prescribe controlled substances to new telehealth patients without an in-person visit
2. Mandatory nationwide PDMP checks before prescribing stimulants
3. Stricter identity verification protocols during video visits
4. Platform registration — telehealth companies will need to register with the DEA

If you already saw a patient in person at least once, these new rules won’t apply to ongoing telehealth care. But for fully remote ADHD treatment (which is where the demand is), you’ll need to comply with whatever the DEA finalizes.

The good news: The DEA received over 38,000 public comments pushing back against overly restrictive proposals (like mandatory in-person visits after 30 days). The rules they’re finalizing appear designed to preserve telehealth access while adding safety guardrails — not kill remote ADHD care entirely.

Bottom line: You have until the end of 2026 under current flexibilities. Use this time to build your telehealth practice, get comfortable with the workflows, and prepare for additional compliance steps in 2027.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Rules: Where the Real Complexity Lives

Federal law sets the floor, but your state determines what you can actually do. Here’s what matters in the six states with the most demand for ADHD telehealth:

California: Telehealth-Friendly, NPs Gaining Independence

Can you prescribe ADHD meds via telehealth? Yes, without restriction.

California law explicitly states that an ‘appropriate prior examination’ for prescribing can be conducted via telehealth — even asynchronously if clinically appropriate. No state law requires an in-person visit beyond federal requirements.

Scope of practice:

• Psychiatrists (MD/DO): Full authority. No special limitations.
• PMHNPs: California is transitioning to Full Practice Authority for experienced NPs. As of 2026, NPs who complete 3 years or 4,600 hours under physician supervision can practice and prescribe independently — including Schedule II stimulants. New grad NPs still need a supervising physician initially.

Key compliance requirements:

• Check the CURES PDMP database before prescribing any Schedule II-IV drug for the first time, then at least every 4 months for ongoing treatment. This is mandatory.
• Use electronic prescribing for controlled substances
• Maintain documentation that meets the standard of care

For out-of-state providers: You need a full California medical license. CA isn’t part of the Interstate Medical Licensure Compact, so expect a lengthy application process.

Reality check: California’s NP independence law is a game-changer. By 2027, experienced PMHNPs will be able to build fully independent telehealth ADHD practices. If you’re an NP in the transitional period, plan your supervision arrangements accordingly.

Texas: Physicians Only for Stimulants

Can you prescribe ADHD meds via telehealth? Yes, but only if you’re a physician.

Texas permits telemedicine for mental health care and doesn’t prohibit telehealth prescribing of stimulants. However, Texas law specifically bars nurse practitioners and PAs from prescribing Schedule II controlled substances in outpatient settings — period. The only exceptions are for hospitalized patients, hospice care, or ER orders.

Scope of practice:

• Psychiatrists (MD/DO): Full authority for telehealth ADHD prescribing
• PMHNPs: Can evaluate and manage ADHD patients, but cannot write the prescription for Adderall, Ritalin, etc. You must have a collaborating physician sign off on any stimulant prescription.

Key compliance requirements:

• Electronic prescribing is mandatory for all controlled substances (no exceptions since 2021)
• PDMP checks aren’t legally required for stimulants in Texas (only for opioids, benzos, barbiturates, and carisoprodol), but it’s strongly recommended
• Standard telemedicine documentation requirements apply

For out-of-state providers: Texas is part of the IMLC, so physicians from compact states can expedite licensure. But you’ll still need that Texas license before treating patients there.

Reality check: If you’re a PMHNP considering telehealth in Texas, understand you’ll be doing diagnostic work and therapy, but a physician will need to handle medication management. This significantly limits solo PMHNP telehealth practices in Texas for ADHD.

Florida: Clear Exception for Psychiatric Care

Can you prescribe ADHD meds via telehealth? Yes — Florida law explicitly allows it.

Florida statute §456.47 generally prohibits prescribing Schedule II controlled substances via telehealth, except for treatment of psychiatric disorders, inpatient care, hospice, or nursing home residents. ADHD treatment clearly falls under ‘psychiatric disorders,’ so you’re covered.

Scope of practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs: Can prescribe stimulants, but must practice under a written protocol with a supervising psychiatrist. Florida’s independence law for NPs excluded psychiatric nurse practitioners. However, psychiatric nurses aren’t subject to the 7-day Schedule II limit that applies to other Florida NPs — you can prescribe full 30-day supplies (or longer if appropriate).

Key compliance requirements:

• Check Florida’s E-FORCSE PDMP before prescribing controlled substances to patients 16 and older
• Use electronic prescribing
• Maintain documentation showing the prescription is for psychiatric treatment (in case of audit)

For out-of-state providers: Florida offers a unique telehealth registration for out-of-state providers. If you’re licensed in another state with a clean record and proper malpractice insurance, you can register to provide telehealth to Florida patients without getting a full Florida license. This registration even allows prescribing controlled substances for psychiatric conditions like ADHD.

Reality check: Florida’s clear statutory exception makes it one of the better states for ADHD telehealth. The out-of-state registration option is particularly valuable if you want to expand your practice geography without the cost and hassle of multiple full licenses.

New York: Recently Aligned with Federal Law

Can you prescribe ADHD meds via telehealth? Yes, as of May 2025.

New York updated its regulations in May 2025 to explicitly allow controlled substance prescribing via telehealth when consistent with federal law. Previously, NY’s rules mirrored the old Ryan Haight requirements. Now, as long as the federal telehealth flexibility is in effect, you can prescribe stimulants via video consult.

Scope of practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs: New York grants significant autonomy. NPs with more than 3,600 hours of experience can practice independently without a written collaborative agreement — including prescribing Schedule II-V controlled substances. No special quantity limits on stimulants.

Key compliance requirements:

• Mandatory I-STOP/PMP registry check before prescribing any Schedule II, III, or IV controlled substance — every single time, no exceptions
• Electronic prescribing required (since 2016)
• Providers need both a DEA registration and a New York State Bureau of Narcotic Enforcement controlled substance license number

Special note: New York allows prescribing up to a 90-day supply of stimulants for ADHD on a single prescription if you indicate it’s for ADHD treatment (use condition code ‘B’ on the prescription). This is unusual and helpful for stable patients — reduces monthly refill hassles.

For out-of-state providers: You need a full New York license. NY isn’t part of IMLC.

Reality check: New York’s 2025 regulatory update removed a major barrier. The mandatory PDMP checks add a step to every prescription, but the 90-day supply option and NP independence make it a strong state for ADHD telehealth.

Pennsylvania: NP Limits on Schedule II

Can you prescribe ADHD meds via telehealth? Yes, no state prohibition beyond federal law.

Pennsylvania doesn’t have specific telehealth prescribing restrictions for controlled substances. The state medical boards permit telemedicine prescribing if the encounter meets the standard of care.

Scope of practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs (CRNPs): Must have a collaborative agreement with a physician. CRNPs are limited to 30-day supplies of Schedule II medications, and any continuation beyond 30 days requires physician approval. The collaborating physician must review Schedule II prescribing monthly.

Key compliance requirements:

• Check the PA PDMP before prescribing any controlled substance at the start of a new course of treatment (and for each opioid/benzo prescription)
• Electronic prescribing mandatory for controlled substances (since 2019)
• Maintain documentation meeting standard of care

For out-of-state providers: Pennsylvania joined IMLC in 2022, so physicians from compact states can expedite licensing.

Reality check: The 30-day Schedule II limit and mandatory physician approval for refills creates extra workflow steps if you’re an NP. In practice, this means your supervising psychiatrist needs to review ADHD cases monthly or give approval for ongoing prescriptions. It’s not prohibitive, but it’s not independent practice either.

Illinois: Two-Tier System for NPs

Can you prescribe ADHD meds via telehealth? Yes, no state restrictions beyond federal law.

Illinois embraced telehealth with a 2021 law strengthening access. No Illinois statute prohibits controlled substance prescribing via telemedicine.

Scope of practice:

• Psychiatrists (MD/DO): Full authority
• PMHNPs (APRNs): Illinois has a two-tier system:
• Without Full Practice Authority: Must work under physician collaboration. Limited to 30-day supplies of Schedule II medications, with physician approval required for any continuation. The physician must review Schedule II prescribing monthly.
• With Full Practice Authority: After 4,000 hours of practice and 250 hours of additional training, NPs can apply for FPA status. FPA APRNs can prescribe stimulants independently — the consultation requirement for Schedule IIs only applies to narcotic drugs (opioids) and benzos, not stimulants for ADHD.

Key compliance requirements:

• Need both a professional license and an Illinois Controlled Substance License to prescribe controlled drugs
• PDMP checks required for opioids and first-time benzos; recommended (but not mandated) for stimulants
• Electronic prescribing expected

For out-of-state providers: Illinois is part of IMLC for physicians. All providers need Illinois licensure plus the state CS license.

Reality check: If you’re an experienced PMHNP, Illinois’s FPA pathway offers true independence for ADHD prescribing. If you’re newer or don’t have FPA, the 30-day limit and physician oversight requirements are similar to Pennsylvania.

A Quick Comparison Table

The Economics: Why Telehealth ADHD Care Makes Sense for Your Practice

Let’s talk numbers, because regulatory compliance is pointless if the economics don’t work.

Traditional patient acquisition is expensive and uncertain:

• DIY marketing (SEO, Google Ads, directory listings) typically costs $200-500+ per acquired patient when you factor in all costs
• SEO takes 6-12 months of consistent investment before generating meaningful patient flow
• Google Ads for mental health keywords run $15-40+ per click, and most clicks don’t convert to booked patients
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers — Zocdoc alone can cost $35-100+ per booking, plus monthly subscription
• Most solo providers lack the expertise or patience for this, and spending $3,000-5,000/month on marketing with uncertain results is a gamble

The telehealth platform model eliminates that risk entirely:

Instead of upfront marketing spend with no guarantee of patient flow, platforms like Klarity Health use a pay-per-appointment model — similar to how Zocdoc charges per booking, but with pre-qualified patients matched to your specialty and availability.

Here’s why this makes economic sense:

• No upfront marketing costs — you don’t spend thousands testing ad campaigns or waiting months for SEO results
• Pre-qualified patient flow — patients are already matched to your expertise and have availability that aligns with your schedule
• Guaranteed ROI — you only pay when a qualified patient actually books with you, not for clicks that go nowhere
• Built-in telehealth infrastructure — no separate platform costs, EHR integration headaches, or billing complexity
• Both insurance and cash-pay options — diversified revenue streams

For ADHD specifically, demand is massive and growing. Patients are actively searching for providers who can prescribe via telehealth. Rather than gambling $3,000-5,000/month on marketing channels that might work eventually, you get immediate access to qualified patients ready to book.

The real question isn’t whether you can afford to join a platform — it’s whether you can afford to waste months and thousands of dollars on DIY marketing that might never pay off.

Common Questions Providers Ask

Q: If the federal extension ends December 31, 2026, can I keep treating my existing telehealth ADHD patients?

Yes. The DEA’s proposed permanent rules clarify that if you’ve seen a patient in person at least once, telehealth follow-ups don’t face additional restrictions. For patients you started treating via telehealth, you’ll likely need to either:

• Obtain the new Telemedicine Special Registration (when available), or
• See them in person at some point, or
• Transition care to another provider

The DEA is expected to provide transition guidance, and platforms like Klarity will help ensure compliance.

Q: What happens if I prescribe stimulants via telehealth in a state that doesn’t allow it?

You’d be violating that state’s medical practice laws, which could result in disciplinary action against your license, DEA registration issues, and potential criminal liability. This is why proper state licensure and understanding state-specific rules is non-negotiable.

Currently, no state outright prohibits ADHD stimulant prescribing via telehealth — but some (like Texas) prohibit certain provider types (NPs) from prescribing stimulants at all.

Q: Do I need malpractice insurance that covers telehealth?

Yes. Most malpractice carriers now include telehealth in standard policies, but verify your coverage explicitly mentions telemedicine/telehealth practice across state lines if you’re treating patients in multiple states.

Q: Can I prescribe a 90-day supply of Adderall via telehealth?

It depends on the state. New York explicitly allows 90-day stimulant prescriptions for ADHD. Most states allow 30-day supplies. Some states restrict NPs to 30-day supplies even if physicians can prescribe longer. Check your state’s specific rules.

Q: What if I’m already treating ADHD patients in person and want to transition some to telehealth?

Once you’ve established a patient relationship in person, telehealth follow-ups are generally allowed in all states (subject to standard of care). You don’t need a separate in-person visit each time, and you can continue prescribing stimulants via video follow-ups. Document the transition and ensure informed consent for telehealth.

Q: Are audio-only (phone) visits acceptable for prescribing ADHD medications?

Generally, no. Federal DEA guidance during the flexibilities requires ‘two-way interactive communication’ which typically means audio-video. Some states (and the DEA for specific situations like buprenorphine) allow audio-only, but for Schedule II stimulants, use video to stay compliant.

What This Means for Your Practice in 2026

If you’re a psychiatrist or PMHNP interested in ADHD telehealth:

1. You can start today. The federal extension through December 2026 gives you a clear window to build your practice, establish patient flow, and refine your protocols.

2. State rules matter more than federal. Know your state’s scope of practice, PDMP requirements, and any quantity limits. If you’re an NP in Texas or Pennsylvania, understand the limitations before you promise patients ongoing stimulant management.

3. Patient acquisition is the real bottleneck. You can be perfectly compliant with every regulation and still struggle to fill your schedule if you’re relying on DIY marketing. A platform that handles patient acquisition, credentialing, and compliance infrastructure removes the guesswork and financial risk.

4. Prepare for 2027 changes. The DEA’s permanent rules will likely require additional steps (special registration, enhanced PDMP checks, identity verification). Start building relationships with platforms that will handle compliance updates for you, so you’re not scrambling when rules change.

5. Documentation is your protection. Whether you’re on a platform or practicing independently, maintain thorough records: clinical justification for diagnosis, documentation of PDMP checks, informed consent for telehealth, and notes demonstrating you’re following standard of care.

Ready to Start Treating ADHD Patients Via Telehealth?

The regulatory landscape for ADHD telehealth isn’t simple, but it’s navigable — especially if you have the right infrastructure supporting you.

Klarity Health handles the complexity so you can focus on patient care:

• Pre-qualified ADHD patients matched to your availability
• Compliance infrastructure that updates with regulatory changes
• Built-in telehealth platform, EHR, and e-prescribing
• Pay-per-appointment model — no marketing spend, no monthly fees, no risk
• Both insurance and cash-pay patient flow

Instead of spending months building a marketing funnel and thousands testing ads, you could be seeing patients next week.

Explore joining Klarity’s provider network →

Citations and Sources

1. DEA & HHS Press Release – Extension of Telemedicine Flexibilities Through 2026. U.S. Department of Health & Human Services. January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Healthcare Dive – Emily Olsen. ‘DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time.’ January 5, 2026. https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/

3. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access.’ U.S. Drug Enforcement Administration. January 16, 2025. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

4. RxAgent Blog – ‘NP Prescriptive Authority by State: 2026 Complete Guide.’ December 28, 2025. https://rxagent.co/blog/np-prescribing-authority

5. Texas Board of Nursing – ‘APRN Frequently Asked Questions: Practice.’ Accessed February 2026. https://www.bon.texas.gov/faqpracticeaprn.asp.html

This article reflects regulations current as of February 10, 2026. Telehealth and controlled substance prescribing laws continue to evolve. Providers should consult with legal counsel and their state medical boards for the most current guidance applicable to their specific practice.

Source:

• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,II%20to%20Schedule%20V%20drugs
• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,to%20hash%20out%20permanent%20regulations
• https://rxagent.co/blog/np-prescribing-authority#:~:text=Proposed%20DEA%20rules%20create%20a,for%20telemedicine%20prescribing
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=there%20any%20settings%20other%20than,may%20prescribe%20Schedule%20II%20controlled
• https://www.ninthdistrict.org/home/2025/05/30/nysdoh-issues-guidance-on-prescribing-controlled-substances-via-telehealth#:~:text=as%20such%20terms%20are%20defined,the%20use%20of%20electronic%20prescribing
• https://www.pacodeandbulletin.gov/secure/pacode/data/049/chapter21/chap21toc.html#:~:text=,
• https://www.ilga.gov/agencies/JCAR/EntirePart?titlepart=06801300#:~:text=match%20at%20L5536%203,collaborating%20physician%20or%20podiatric%20physician
• https://rxagent.co/blog/np-prescribing-authority#:~:text=However%2C%20,3
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care